Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New antiinflammatory and analgesic compounds in development at Roche

March 5, 1998

Idec, SKB announce development plans for clenoliximab

March 3, 1998

Boehringer Ingelheim reveals new antiinflammatory agents

March 3, 1998

AutoImmune will conduct pivotal study of Colloral

Feb. 27, 1998

Beneficial effects of FK-506 in animal model of rheumatoid arthritis

Feb. 27, 1998

Orthovisc PMA accepted for filing by FDA

Feb. 25, 1998

Selective inhibitor of p38 MAP kinase effective in chronic inflammatory diseases

Feb. 25, 1998

Flobufen update

Feb. 24, 1998

First phase II results reported for EuroAlliance's DAAID

Feb. 23, 1998

Patent coverage for Idec's humanized antibody for SLE

Feb. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...